Algorics’ CEO Nithiya Ananthakrishnan to speak at Clinical Technology Symposium, 12 September 2017

Algorics’ CEO Nithiya Ananthakrishnan joins industry experts from Chiltern International and OmniComm Systems, as they take on the topic, ‘What Does ICH E6 R2 Mean for Risk-Based Monitoring (RBM) and Clinical Trials?’. The Clinical Technology Symposium, taking place on Tuesday … Read More